Determination and pharmacokinetic study of tussilagone in rat plasma by RP‐HPLC method
- 23 July 2008
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 22 (11), 1194-1200
- https://doi.org/10.1002/bmc.1042
Abstract
A simple and rapid high‐performance liquid chromatographic method was used to study the pharmacokinetics of tussilagone, one of the main bioactive constituents in the flower buds of Tussilago farfara L. of traditional Chinese medicines, in rat plasma. Plasma was deproteinized by ethyl acetate for sample clean‐up. The drugs were separated on a Dikma Diamonsil™ C18 column (4.6 × 250 mm, 5.0 µm), and detected by UV absorption at 220 nm. Methanol–water (75:25, v/v) was used as the mobile phase. It was applied to the pharmacokinetic study of tussilagone in rats after a dose of 5 mg/kg by intravenous administration and a dose of 200 mg/kg by intragastrical administration. A biphasic phenomenon with a rapid distribution followed by a slower elimination phase was observed from the plasma concentration–time curve by intravenous administration, while the plasma concentration–time curve of tussilagone conformed to a one‐compartment model by intragastrical administration. The absolute bioavailability of tussilagone is about 1.31%. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 5 references indexed in Scilit:
- Pharmacokinetics of Paeonol after Intravenous Administration in RatsJournal of Pharmaceutical Sciences, 1994
- Evaluation of tussilagone: A cardiovascular-respiratory stimulant isolated from Chinese herbal medicineGeneral Pharmacology: The Vascular System, 1988
- L-652,469 - a dual receptor antagonist of platelet activating factor and dihydropyridines from Tussilago farfara LEuropean Journal of Pharmacology, 1987
- Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equationsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Estimating the Dimension of a ModelThe Annals of Statistics, 1978